Santegoets, Saskia J.
Welters, Marij J. P.
Schrikkema, Deborah S.
Freriks, Manon R.
Kok, Hanna
Weissbrich, Bianca
van den Branden, Anouk
Linnemann, Carsten
Schumacher, Ton N.
Adhikary, Sabina
Bendle, Gavin
van der Burg, Sjoerd H.
Funding for this research was provided by:
Oncode base fund to SHvdB
Article History
Received: 5 May 2022
Accepted: 8 December 2022
First Online: 16 December 2022
Declarations
:
: DSS, MFR, HK, BW, AvdB, CL and GB were full-time employees of KITE Pharmaceuticals at the time of data acquisition. SA is currently a full-time employee of KITE Pharmaceuticals. The other authors declare no potential conflicts of interest for the submitted work.
: SHvdB has received base funding from the Oncode Institute.
: The study was performed in accordance with the Declaration of Helsinki and approved by the local medical ethical committee of the Leiden University Medical Center (LUMC, P08-197 and P07-112) and in agreement with the Dutch law. Patients were included after signing informed consent.